LNZ Tablet is primarily used in the management of serious infections caused by susceptible Gram-positive bacteria, especially those that are resistant to other common antibiotics. This medicine belongs to the oxazolidinone class of antibiotics and contains Linezolid, which works by inhibiting the initiation of bacterial protein synthesis, thereby stopping the bacteria from growing and replicating. It is specifically indicated for conditions such as nosocomial pneumonia, community-acquired pneumonia, complicated skin and skin structure infections, and Vancomycin-resistant Enterococcus faecium infections, and may be used for multidrug-resistant tuberculosis when other options fail.
50.1% CHEAPER








































































